Clinical aspects and cytokine response in adults with seasonal influenza infection

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5593-5602

  Bian, Jia Rong ^a,b   Nie, Wei ^b   Zang, Yuan Sheng ^b   Fang, Zheng ^b   Xiu, Qing Yu ^b   Xu, Xing Xiang ^a  

^a YANGZHOU UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adults; Clinical aspects; Cytokine; Immunity; Seasonal influenza A; Seasonal influenza B

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 29; INTERLEUKIN 32; INTERLEUKIN 33; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN; ZANAMIVIR;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; SEASONAL INFLUENZA; VIRUS DIAGNOSIS;

ORTHOMYXOVIRIDAE;

EID: 84921469234     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. World Health Organization: (WHO). Influenza (Seasonal). Available: http//www.Who.int/mediacentre/factsheets/fs211/en/index.html. Accessed 19 Oct 2011.
2. World Health Organization. Influenza. Available: http://www.who.int/topics/influenza/en. Accessed 1 May 2011.
3. Weycker D, Edelsberg J, Halloran ME, Longini IM Jr, Nizam A, Ciuryla V, Oster G. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23: 1284-1293.
4. Tsou TP, Shao PL, Lu CY, Chang LY, Kao CL, Lee PI, Yang P., Lee CY, Huang LM. Viral load and clinical features in children infected with seasonal influenza B in 2006/2007. J Formos Med Assoc 2012; 111: 83-7.
5. Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, Ngai KL, Lui GC, Wong BC, Lee SK, Choi KW, Hui DS. Cytokine response patterns in severe pandemic 2009 h1n1 and seasonal influenza among hospitalized adults. PLoS One 2011; 6: e26050.
6. Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999; 282: 1240-6.
7. Wang J, Nikrad MP, Travanty EA, Zhou B, Phang T, Gao B, Alford T, Ito Y, Nahreini P, Hartshorn K, Wentworth D, Dinarello CA, Mason RJ. Innate immune response of human alveolar macrophages during influenza A infection. PLoS One 2012; 7: e29879.
8. Wu S, Metcalf JP, Wu W. Innate immune response to influenza virus. Curr Opin Infect Dis 2011; 24: 235-240.
9. Kim YH, Kim JE, Hyun MC. Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection. Pediatr Pulmonol 2011; 46: 1233-1239.
10. Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, Laslo C, Hagau R, Petrescu M, Studnicska DM. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 2010; 14: R203.
11. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997; 337: 874-880.
12. Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, Fang J, Zhang W, Wu J, Zhu Y. IL-32: a host proinflammatory factor against influenza□viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol 2010; 185: 5056-5065.
13. Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled european study. J Infec 2000; 40: 42-48.
14. Puhakka T, Lehti H, Vainionpää R, Jormanainen V, Pulkkinen M, Sharp S, Kerr C, Dempsey M, Ring CJ, Ward C, Tisdale M. Zanamivir: a Significant Reduction in Viral Load During Treatment in Military Conscripts with Influenza. Scand J Infect Dis 2003; 35: 52-58.
15. Lee SM, Chan RW, Gardy JL, Lo CK, Sihoe AD, Kang SS, Cheung TK, Guan YI, Chan MC, Hancock RE, Peiris MJ. Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res 2010; 11: 147.
16. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL, Mason RJ. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol 2009; 182: 1296-304.
17. Le Goffic R, Arshad MI, Rauch M, L’Helgoualc’h A, Delmas B, Piquet-Pellorce C, Samson M. Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol 2011; 45: 1125-32.
18. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of daptive immunity. Nat Immunol 2011; 12: 631-638.
19. Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, Yoshikawa T, Kubota-Koketsu R, Ikuta K, Okamoto S, Mori Y, Kunisawa J, Kiyono H, Itoh N, Nagano K, Kamada H, Tsutsumi Y, Tsunoda S. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol 2010; 84: 12703-12.
20. Kang YM, Song BM, Lee JS, Kim HS, Seo SH. Pandemic H1N1 influenza virus causes a stronger inflammatory response than seasonal H1N1 influenza virus in ferrets. Arch Virol 2011; 156: 759-767.
21. Guan X, Yang W, Sun X, Wang L, Ma B, Li H, Zhou J. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction. Inflamm Res 2012; 61: 591-8.
22. Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, Banner D, Ng DC, Socias L, Loza A, Andaluz D, Maravi E, Gómez-Sánchez MJ, Gordón M, Gallegos MC, Fernandez V, Aldunate S, León C, Merino P, Blanco J, Martin-Sanchez F, Rico L, Varillas D, Iglesias V, Marcos MÁ, Gandía F, Bobillo F, Nogueira B, Rojo S, Resino S, Castro C, Ortiz de Lejarazu R, Kelvin D. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care 2010; 14: R167.
23. Lee N, Chan PK, Wong CK, Wong KT, Choi KW, Joynt GM, Lam P, Chan MC, Wong BC, Lui GC, Sin WW, Wong RY, Lam WY, Yeung AC, Leung TF, So HY, Yu AW, Sung JJ, Hui DS. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A (H1N1) virus pneumonia. Antivir Ther 2011; 16: 237-247.
24. Wu W, Booth JL, Duggan ES, Wu S, Patel KB, Coggeshall KM, Metcalf JP. Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology 2010; 396: 178-188.
25. Nakajima N, Van Tin N, Sato Y, Thach HN, Katano H, Diep PH, Kumasaka T, Thuy NT, Hasegawa H, San LT, Kawachi S, Liem NT, Suzuki K, Sata T. Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam. Mod Pathol 2013; 26: 357-69.
26. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 2008; 376: 53-59.
27. McGill J, Heusel JW, Legge KL. Innate immune control and regulation of influenza virus infections. J Leukoc Biol 2009; 86: 803-812.
28. Matsumoto Y, Kawamura Y, Nakai H, Sugata K, Yoshikawa A, Ihira M, Ohashi M, Kato T, Yoshikawa T. Cytokine and chemokine responses in pediatric patients with severe pneumonia associated with pandemic A/H1N1/2009 influenza virus. Microbiol Immunol 2012; 56: 651-5.
29. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr. Comparison of proinflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol 2011; 200: 53-60.
30. Kim SR, Lee KS, Park SJ, Min KH, Lee KY, Choe YH, Lee YR, Kim JS, Hong SJ, Lee YC. PTEN down-regulates IL-17 expression in a murine model of toluene diisocyanate-induced airway disease. J Immunol 2007; 179: 6820-6829.
31. Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, Chadha MS, Sangle SA, Kadam DB. Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One 2010; 5: e13099.
32. Augustine JJ, Hricik DE. T-cell immune monitoring by the ELISPOT assay for interferon gamma. Clin Chim Acta 2012; 413: 1359-63.
33. Agrati C, Gioia C, Lalle E, Cimini E, Castilletti C, Armignacco O, Lauria FN, Ferraro F, Antonini M, Ippolito G, Capobianchi MR, Martini F. Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course. J Infect Dis 2010; 202: 681-689.
34. Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, Dinarello CA. Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 2008; 181: 557-565.
35. He S, Li T, Chen H, Ma W, Yao Q, Yang H, Wang H, Wang F, Zhao C, Yang P. CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation. Allergy 2011; 66: 238-246.
36. Jordan WJ, Eskdale J, Boniotto M, Rodia M, Kellner D, Gallagher G. Modulation of the human cytokine response by interferon λ-1 (IFN-λ1/IL-29). Genes Immun 2007; 8: 13-20.
37. Pekarek V, Srinivas S, Eskdale J, Gallagher G. Interferon λ-1 (IFN-λ1/IL-29) induces ELR- CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-γ-independent manner. Genes Immun 2007; 8: 177-180.
38. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNF alpha. Immunity 2005; 22: 131-142.
39. Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH. IL-32 synergizes with nucleotide oligomerization domain (NOD)1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A 2005; 102: 16309-16314.
40. Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST, Gao Y, Kang L, Hao Q, Peng G, Chen Y, Chen X, Wu J, Zhu Y. Activation of interleukin-32 proinflammatory pathway in response to influenza A virus infection. PLoS One 2008; 3: e1985.
41. Li W, Yang F, Liu Y, Gong R, Liu L, Feng Y, Hu P, Sun W, Hao Q, Kang L, Wu J, Zhu Y. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol 2009; 39: 1019-1024.
42. Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, Yoshikawa T, Kubota-Koketsu R, Ikuta K, Okamoto S, Mori Y, Kunisawa J, Kiyono H, Itoh N, Nagano K, Kamada H, Tsutsumi Y, Tsunoda S. Interleukin-1 family cytokines as mucosal vaccine adjuvants for in duction of protective immunity against influenza virus. J Virol 2010; 84: 12703-12712.